Clinical Trial Update: Trial of Nivolumab Following Partially Human Leukocyte Antigen (HLA) Mismatched BMT in Children & Adults With Sarcoma [Phase 1, Phase 2]

View source ↗

Summary

This listing describes a Phase 1/Phase 2 clinical trial of Nivolumab after partially HLA-mismatched bone marrow transplantation in children and adults with sarc…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Sarcoma
• Solid Tumor

Drugs mentioned

• nivolumab (nivolumab)

Snippet

Sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | Conditions: Sarcoma, Solid Tumor, Adult | Phase 1, Phase 2 | Status: RECRUITING